胸壁加压在急性呼吸窘迫综合征中的应用和临床进展  

Clinical research progress of external chest-wall compression in acute respiratory distress syndrome

作　　者：倪韫晖 杨毅[1] 袁雪燕 邱海波[1] Ni Yunhui;Yang Yi;Yuan Xueyan;Qiu Haibo(Jiangsu Provincial Key Laboratory of Critical Care Medicine,Department of Critical Care Medicine,Zhongda Hospital,School of Medicine,Southeast University,Nanjing 210009,China)

机构地区：[1]江苏省重症医学重点实验室,东南大学附属中大医院重症医学科,南京210009

出　　处：《中华重症医学电子杂志》2024年第3期243-247,共5页Chinese Journal Of Critical Care & Intensive Care Medicine(Electronic Edition)

基　　金：国家自然科学基金重点项目(81930058);国家自然科学基金专项(82341032);科技部国家重点研发计划项目(2022YFC2504400)

摘　　要：在新型冠状病毒感染(COVID-19)引起的急性呼吸窘迫综合征(ARDS)中,恰当地对胸壁施加外部压力可能会产生益处,这对传统的肺保护性通气策略构成了挑战。近年来,许多研究显示胸壁加压可以改善部分ARDS患者的氧合及呼吸力学,但是胸壁加压的治疗价值仍存在争议。本文主要就胸壁加压的生理学效应、实施方法及临床应用等方面作一综述。In managing novel coronavirus disease 2019(COVID-19)associated acute respiratory distress syndrome(ARDS)patients,proper external chest-wall compression may be beneficial,making it a big challenge to rethink about traditional lung protective ventilation strategies.In recent years,many studies have shown that external chest-wall compression can improve oxygenation and respiratory mechanics in ARDS patients,but therapeutic result remains controversial.This article mainly reviews physiological effects,implementation methods and clinical applications of chest wall compression.

关 键 词：急性呼吸窘迫综合征 机械通气 呼吸力学 胸壁加压 

分 类 号：R563.8[医药卫生—呼吸系统]